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Background: Intra-abdominal adhesions and their complications occur frequently after laparotomy. The aim 
of this study was to compare oral versus intraperitoneal administration of simvastatin in decreasing post-
laparotomy adhesions in rat. 
Methods: Thirty male Wistar albino rats were divided into three groups of ten. All the rats underwent 
laparotomy and induction of adhesions using the method of Meso-Stitch approximation of injured cecum and 
abdominal wall. One group received oral simvastatin (40 mg/kg) daily during two weeks before the 
laparotomy. In the two other groups, 2 ml of solution of simvastatin (40 mg/kg) or distilled water (as placebo) 
was spilled into abdomen before closing abdominal wall, respectively. After 14 days, all the rats were put 
under laparotomy again to be compared. Rates and grades of adhesions were assessed using Hoffman et al. and 
Lauder et al. Scale and histopathological reports. 
Results: In placebo group, the grade II and III adhesion was seen in 2 and 8 rats, respectively. In local 
simvastatin group, there was no adhesion in 5 rats, and grade I and II adhesion was seen in 3 and 2 rats, 
respectively. In oral simvastatin group, 6 rats were without adhesion, and 3 cases with grade I and 1 case with 
grade II adhesion. The frequency and grade of adhesion were statistically different in simvastatin groups 
compared to the placebo group (P < 0.001), but not with each other. 
Conclusions: Oral simvastatin for two weeks before the laparotomy can reduce post-laparotomy adhesion 
bands as well as local administration of simvastatin solution. 
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Introduction 
Annually, over 300000 patients undergo surgery for the 
treatment of intestinal obstruction due to adhesions in 
the United States (1) and 20-years analysis (1988 to 
2007) did not show any reduction in this amount (2).  
Although all the patients with adhesion do not show 
clinical signs, but early or late intestinal obstruction  
(49-79 percent), chronic abdominal pain (20-70 percent) 
and infertility (15-20 percent) are considered as the 
major surgical problems (1).  
The studies using serial laparoscopies showed that 
at the 8th day after the surgery, 55% of the adhesions 
are appeared and 100% of them were visible between 
the 4th to 8th weeks (3,4). Although laparoscopy and 
microsurgery techniques have reduced the formation of 
adhesions, but the benefits of adjuvant use of different 
substances, despite their widespread use, is still 
questionable (5).  
Many drugs, such as anti-inflammatory or 
fibrinolytic agents and physical barriers are 
recommended; but there is still no ideal substance to 
prevent adhesions. Hyaluronic acid, Intergel 
(hyaluronic acid binding ferric ion), Sepracoat 
(combination of hyaluronic acid and carboxymethyl 
cellulose), Hydrogel (spray gel), Viscogels and statins 
are of the substances used to reduce the adhesion (6-8). 
The only drug that is partly been proven to reduce the 
adhesion is the hyaluronate that is not available to 
everyone and interferes in the restoration of 
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anastomoses (1). Therefore, efforts are ongoing to 
examine other factors in reducing adhesions. Among 
these factors, are the statins that have anti-
inflammatory and fibrinolytic effects (9).  
According to the our previous study and the 
positive effect of local simvastatin at a dose of 30 mg 
per kg of body weight in preventing the formation of 
adhesion bands in rats (6), and based on similar studies 
and the significant effect of oral statins prior to 
laparotomy in this animal model (8), this study aimed 
to investigate the anti-adhesion effect of oral and 
intraperitoneal simvastatin, compared to placebo 
(distilled water) in vivo conditions. 
 
Materials and Methods 
In this experimental study, 30 adult male Wistar albino 
rats weighing 250 to 300 g with the age of 4-6 months 
and the same race were selected and divided into three 
groups of ten. In the first group, during two weeks 
before the study, oral simvastatin HEXAL (Germany) 
with the dose of 40 mg/kg dissolved in water was 
administrated daily. 
This study was done under the regarding the Guide 
for the Care and Use of Laboratory Animal provided 
by Shahid Beheshti Laboratory Animals Center in 
accordance with global standards for laboratory 
biosafety guidelines (10). The rats were housed in the 
animal nest of the Department of Anatomy in School of 
Medicine. The study was approved by the institutional 
review board and the Ethics Committee of Shahid 
Beheshti University of Medical Sciences, Iran. 
The rats were intramuscularly anesthetized with 
ketamine 60 mg/kg ROTEXMEDICA (Germany) and 
then, underwent midline laparotomy incision with the 
length of 4 cm. In all three groups, powder-free gloves 
were used during the surgery. To create adhesion, 
according to Daniel study, the method of Meso-Stitch 
approximation of injured cecum and abdominal wall 
was used in this way: scratching with a blade on the 
cecum and creating one-square-centimeter defects on 
the abdominal wall and creating sutures for abdominal 
wall and the skin with 3-0 nylon (11). All the rats 
underwent the surgery in one day. 
At the end of the surgery, in the second and groups, 
before closing the abdomen, 2 cc of simvastatin 
solution (40 mg/kg) and 2 cc distilled water as placebo 
was spilled into abdomen, respectively, and then the 
abdomen was closed. For the first group, that had 
received drug for two weeks, nothing was 
administrated in this step.  
After two weeks, the rats were reevaluated in terms 
of adhesions. They were anesthetized using ketamine 
and then euthanized using chloroform gas; re-
laparotomy was performed and adhesions in the three 
groups were compared via observation during the 
surgery based on the quantitative questionnaire of 
Hoffman et al. use by Poehnert et al. (11), observation 
during surgery based on the qualitative questionnaire of 
Lauder et al. (12), and histological reports (biopsy). 
The degree of clinical adhesion was scaled as:  
0: No adhesion, 1: One adhesion band, no vessel, easily 
separated, 2: Two thin adhesion bands, no vessel, 
easily separated, 3: Three thin adhesion bands, no 
vessel, easily separated, and 4: More than three thin 
adhesion bands, easily separated with no vessel or 
diffuse adhesion bands with vessels (13).  
The degree of pathological adhesion was scaled as: 
0: No adhesion, 1: Fat (Figure 1), 2: Fat and fibrosis, 
and 3: Fibrosis (Figure 2). 
 
 
Figure 1. Fourth-degree intra-abdominal adhesion in a rat 
receiving normal saline (control group). Note the 
intraperitoneal adhesion between the colon and the 
mesothelium of small intestine. More than three thin 
adhesion bands, easily separated with no vessel or diffuse 
adhesion bands with vessels 
 
The obtained data were analyzed using Kruskal-
Wallis and Mann-Whitney U evaluated using SPSS 
software (version 20, IBM Corporation, Armonk, NY) 
at the significant level of P < 0.050.  
 
 
Figure 2. First-degree intra-abdominal adhesion in a rat 
receiving normal saline (local simvastatin group). Note the 
intraperitoneal loose adhesion between the colon and the 
mesothelium of small intestine. One adhesion band, no 
vessel, easily separated 
 
Results 
Totally, 30 male Wistar albino rats weighing 250-300 g 
with the age of 5-6 months underwent were included in 
the study. The duration of each surgery was  
20 minutes. No mortality was recorded. The volume of 
intraoperative bleeding was comparable between groups. 
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Table 1. Comparison of the degree of clinical adhesion between the study groups 







0: No adhesion 5 (50) 6 (60) 0 (0) 
1: One adhesion band, no vessel, easily separated 3 (30) 1 (10) 0 (0) 
2: Two thin adhesion bands, no vessel, easily separated 2 (20) 3 (30) 0 (0) 
3: Three thin adhesion bands, no vessel, easily separated 0 (0) 0 (0) 2 (20) 
4: More than three thin adhesion bands, easily separated with no vessel 
or diffuse adhesion bands with vessels 
0 (0) 0 (0) 8 (80) 
P < 0.001 between the both simvastatin groups and placebo group, P = 0.910 between the simvastatin groups 
 
Clinical finding showed that in placebo group,  
8 cases had grade 4 and 2 rats had grade 3 adhesions; 
while in intra-abdominal and oral simvastatin groups,  
5 and 6 cases did not have adhesion, respectively. 
Based on the clinical findings, the formation of severe 
adhesions in the oral and topical simvastatin groups 
was significantly less than the placebo group  
(P < 0.001); but no significant difference was observed 
between the two simvastatin groups (P = 0.910) (Table 1). 
Based on the pathological findings, the formation of 
fibrosis in the oral and topical simvastatin groups was 
significantly less than the placebo group (P < 0.001); 
there were no significant difference between the two 
simvastatin groups (P = 0.907) (Table 2). 
 
Discussion 
The findings of this study showed that oral and local 
administration of simvastatin can reduce the formation 
of intra-abdominal adhesions following laparotomy. 
Arons et al., in an experimental study on rats, 
examined the effect of statins in the prevention of 
adhesion and its effect on wound healing. Oral and 
topical atorvastatin (30 mg/kg) were administrated into 
two groups of 15 rats. After 7 days, repeated 
laparotomy showed that only in the topical type, 
adhesion formation reduced (3). This is not consistent 
with the findings of this investigation in oral form. In 
this study, simvastatin with a dose of 40 mg/kg was 
used and in both oral and topical groups, decreased 
clinical and pathological adhesion after 14 days.  
Hoşcan et al. study was conducted on 40 rats with 
fluvastatin. In the group of intra-abdominal fluvastatin 
with dosage of 10 mg/kg, all the rats died after one day 
and this group was excluded from the study. But in the 
oral group with the same dosage, reduction in adhesion 
was observed after two weeks (9). In our study, 
simvastatin was used and none of the rats died. Perhaps, 
because of the influence of different groups of different 
classes of statins, all the rats which received topical 
fluvastatin, died Actachir et al. study. This is the reason 
that simvastatin was used in the present study. 
Kucuk et al. by administering 0.57 mg/kg 
intraperitoneal simvastatin and measurement of tissue-
type plasminogen activator (t-PA) in the abdomen in 
30 rats, after a week, found that reducing adhesions in 
the abdominal cavity is associated with increased levels 
of t-PA (13). In the present study, the adhesion criteria 
was the clinical and histological observation and 
laboratory criteria were not used. 
Jahovic et al. showed that the two drugs of 
simvastatin and fluvastatin were not similar in 
decreasing inflammatory parameters in colitis in two 
groups of 10 rats. Fluvastatin decreased the colon 
tissue collagen content and the level of tumor necrosis 
factor (TNF) more (14). In the case of simvastatin, the 
capacity of hydroxyl radicalism is more, while 
fluvastatin had higher antioxidants for taking the anti-
peroxyl radicals (15). Fluvastatin, decreased the 
monocyte CD11b expression and endothelial adhesion, 
too (16).  
In Hoşcan et al. study, the effect of fluvastatin on 
wound healing was measured by wound 
hydroxyproline content which did not differ with the 
control sample and the effect of simvastatin on the 
restoration of tissues was not studied (9). This is one of 
the issues that must be evaluated for assessment of the 
effects of drug on the anastomosis to determine whether 
topical or oral simvastatin impairs healing or not.  
Yildiz et al. showed that oral simvastatin had no 
effect in reducing adhesions (8); their findings are not 
consistent with this study. In the Yildiz et al. study, 
simvastatin was given just 48 hours before the 
laparotomy, whereas in the present study, the 
medication was given 14 days prior to surgery (8). 
Another difference is that they performed another 
laparotomy 7 days later, while this was done after 14 
days in the present study. 
 
Table 2. Comparison of the degree of pathological adhesion between the study groups 
The degree of pathological adhesion Local simvastatin [n (%)] Oral simvastatin [n (%)] Placebo [n (%)] 
0: No adhesion 5 (50) 6 (60) 0 (0) 
1: Fat 3 (30) 1 (10) 0 (0) 
2: Fat and fibrosis 2 (20) 3 (30) 2(20) 
3: Fibrosis 0 (0) 0 (0) 8 (80) 
P < 0.001 between the both simvastatin groups and placebo group, P = 0.907 between the simvastatin groups 
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The adhesion criterion in that study was the activity 
of t-PA, which did not increase in oral form. Although 
the dose of simvastatin was similar to the present 
study, but perhaps with 48 hours of oral medication, 
the appropriate level of the drug was not created in 
mesothelial cells. 
In a pilot study on human model, analyzing the data 
of 46 patients on oral simvastatin for 3-7 days before 
the surgery did not show any significant difference on 
the level of t-PA and plasminogen activator inhibitor-1 
(PAI-1) compared to control group at the first day after 
the surgery (17). The shortness of sample size as well 
as the low duration of drug administration, were the 
limitations of that pilot study.  
In another human study, oral administration of  
40 mg of simvastatin from 3-7 days before the surgery 
to 4 days after it, tended to significant decrease of 
inflammatory factors (18). 
Haslinger et al. in in-vitro study on mesothelial 
cells showed that simvastatin stimulated fibrinolytic 
activity with increasing levels of t-PA and decreasing 
PAI-1 (19). In another study, Bea et al. showed that 
simvastatin was the stimulant of fibrinolytic system in 
mesothelial cells by reducing TNF-a (20). We showed 
the effect of local simvastatin (30 mg/kg body weight) 
in reducing adhesion, with a significant difference 
compared to the control group in a sample of 32 rats 
with clinical and pathological criteria (6). 
 
Conclusion 
The present study showed that oral simvastatin similar 
to topical simvastatin was significantly effective in 
reducing adhesion compared to the control group in 
rats. More studies are also needed on human subjects to 
examine the effects on healing of anastomosis.  
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